Literature DB >> 2467926

Microassay for prostatic androgen receptors correlated with quantitative histological assessment.

S M Widdowson1, J L Ostrowski, V J Dangerfield, S C Harris, P M Ingleton, J C Underwood, J L Williams, M A Parsons.   

Abstract

A new microassay in which cryostat sections of prostate tissue were used to provide the source of soluble androgen receptor for biochemical assay, was devised using an isoelectric focusing method, with [3H]-mibolerone as the androgenic radioligand. Adjacent cryostat sections from the same tissue block were stained for diagnostic and quantitative histological assessment. The assay was used to illustrate variations in tissue androgen receptor concentration for correlation with epithelial cell content in benign prostate hyperplasia and prostatic cancer, and to show the effects of androgen receptor concentration of resection of prostatic tissue by electroresection. The results indicate that the heat in electroresection renders prostatic tissue unsuitable for androgen receptor assays, and suggest that knowledge of the cellular composition of carcinomatous prostates may be of importance in the full assessment of androgen receptor assay results. This method incorporates both a biochemical assay and histological assessment of the assayed tissue on near-facsimile sections, an advantage over conventional biochemical assays.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467926      PMCID: PMC1141877          DOI: 10.1136/jcp.42.3.322

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  The histology of the human foetal and prepubertal prostates.

Authors:  G S ANDREWS
Journal:  J Anat       Date:  1951-01       Impact factor: 2.610

2.  Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.

Authors:  S Akimoto; H Fuse; R Sato; S Zama; J Shimazaki
Journal:  Endocrinol Jpn       Date:  1985-02

3.  The prostate and prostatic urethra: a morphologic synthesis.

Authors:  J E McNeal
Journal:  J Urol       Date:  1972-06       Impact factor: 7.450

4.  Physiocochemical properties of the 5 -dihydrotestosterone binding protein in human male serum.

Authors:  V Hansson; J Larsen; E Reusch
Journal:  Steroids       Date:  1972-11       Impact factor: 2.668

5.  Effects of gamma-aminobutyric acid receptor agonists on the secretion of growth hormone, luteinizing hormone, adrenocorticotrophic hormone and thyroid-stimulating hormone from the rat pituitary gland in vitro.

Authors:  R A Anderson; R Mitchell
Journal:  J Endocrinol       Date:  1986-01       Impact factor: 4.286

6.  Use of a new radioactive ligand, 7 alpha, 17 alpha-dimethyl[17 alpha-methyl 3H]19-nortestosterone for the estimation of androgen receptors in rat liver cytosol.

Authors:  P Bannister; P Sheridan; M S Losowsky
Journal:  J Steroid Biochem       Date:  1985-07       Impact factor: 4.292

Review 7.  Androgen receptor assays in advanced prostatic cancer.

Authors:  R Buttyan; C A Olsson
Journal:  Urol Clin North Am       Date:  1984-05       Impact factor: 2.241

8.  Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study.

Authors:  J W Ironside; R D Battersby; V J Dangerfield; M A Parsons; W R Timperley; J C Underwood
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

9.  Oestrogen receptor assay of cryostat sections of human breast carcinomas with simultaneous quantitative histology.

Authors:  J C Underwood; V J Dangerfield; M A Parsons
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

10.  A morphometric analysis of human breast carcinoma.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

View more
  1 in total

1.  Microassays for androgen and progesterone receptor quantitation as compared with standard saturation analyses in human prostatic tissues.

Authors:  J Brolin; P Ekman
Journal:  Urol Res       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.